HEPATIC IMPAIRMENT (HI)
Clinical trials for HEPATIC IMPAIRMENT (HI) explained in plain language.
Never miss a new study
Get alerted when new HEPATIC IMPAIRMENT (HI) trials appear
Sign up with your email to follow new studies for HEPATIC IMPAIRMENT (HI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug EDG-7500 put to the test in liver health study
Knowledge-focused Recruiting nowThis early-stage study is testing a single dose of an experimental drug called EDG-7500 in 32 adults. Some have mild or moderate liver problems, while others have normal liver function. Researchers want to see how the drug moves through the body and if it is safe in people with d…
Matched conditions: HEPATIC IMPAIRMENT (HI)
Phase: PHASE1 • Sponsor: Edgewise Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Liver study tests how body handles experimental drug
Knowledge-focused Recruiting nowThis early-stage study looks at how the experimental drug nemtabrutinib is processed in people with moderate liver impairment compared to healthy volunteers. About 32 adults will receive a single oral dose, and researchers will measure drug levels in the blood over time. The goal…
Matched conditions: HEPATIC IMPAIRMENT (HI)
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC